BIOMAT Database Logo BIOMAT Database Logo

Adrenocorticotropic hormone-independent bilateral adrenocortical macronodular hyperplasia: a case report and immunohistochemical studies. 1994

S Koizumi, and M Beniko, and A Ikota, and H Mizumoto, and K Matsuya, and A Matsuda, and S Sakuma, and Y Mashio, and H Kunita, and K Okamoto
Department of Internal Medicine, Kin-ikyo Chuo Hospital, Sapporo, Japan.

A 55-year-old woman developed Cushing's syndrome due to ACTH-independent bilateral adrenocortical macronodular hyperplasia. Plasma ACTH was undetectable, and was not stimulated by administration of metyrapone, CRH, or insulin. Hypercortisolism was not suppressed by a high dose of dexamethasone, but was responsive to ACTH. Both adrenal glands were enlarged with a total weight of 200 g, and contained multiple nodules composed of two cell types (large clear cells and small compact cells). In immunohistochemical studies, P450c17 immunoreactivity was predominantly observed in small compact cortical cells, while that of 3 beta HSD was observed exclusively in large clear cortical cells. This pattern of expression of steroidogenic enzymes as well as histological and clinical features is considered to be unique to ACTH-independent bilateral adrenocortical macronodular hyperplasia.

UI MeSH Term Description Entries
D006965 Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. Hyperplasias
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003480 Cushing Syndrome A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent. Cushing's Syndrome,Hypercortisolism,Syndrome, Cushing,Syndrome, Cushing's
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000302 Adrenal Cortex The outer layer of the adrenal gland. It is derived from MESODERM and comprised of three zones (outer ZONA GLOMERULOSA, middle ZONA FASCICULATA, and inner ZONA RETICULARIS) with each producing various steroids preferentially, such as ALDOSTERONE; HYDROCORTISONE; DEHYDROEPIANDROSTERONE; and ANDROSTENEDIONE. Adrenal cortex function is regulated by pituitary ADRENOCORTICOTROPIN. Cortex, Adrenal
D000324 Adrenocorticotropic Hormone An anterior pituitary hormone that stimulates the ADRENAL CORTEX and its production of CORTICOSTEROIDS. ACTH is a 39-amino acid polypeptide of which the N-terminal 24-amino acid segment is identical in all species and contains the adrenocorticotrophic activity. Upon further tissue-specific processing, ACTH can yield ALPHA-MSH and corticotrophin-like intermediate lobe peptide (CLIP). ACTH,Adrenocorticotropin,Corticotropin,1-39 ACTH,ACTH (1-39),Adrenocorticotrophic Hormone,Corticotrophin,Corticotrophin (1-39),Corticotropin (1-39),Hormone, Adrenocorticotrophic,Hormone, Adrenocorticotropic

Related Publications

S Koizumi, and M Beniko, and A Ikota, and H Mizumoto, and K Matsuya, and A Matsuda, and S Sakuma, and Y Mashio, and H Kunita, and K Okamoto
Adrenocorticotropic hormone-independent adrenocortical hyperplasia and ACTH-independent bilateral adrenocortical macronodular hyperplasia.
August 1997, Internal medicine (Tokyo, Japan),
S Koizumi, and M Beniko, and A Ikota, and H Mizumoto, and K Matsuya, and A Matsuda, and S Sakuma, and Y Mashio, and H Kunita, and K Okamoto
Adrenocorticotropic hormone-independent bilateral adrenocortical macronodular hyperplasia treated with mitotane.
December 1999, Internal medicine (Tokyo, Japan),
S Koizumi, and M Beniko, and A Ikota, and H Mizumoto, and K Matsuya, and A Matsuda, and S Sakuma, and Y Mashio, and H Kunita, and K Okamoto
Preclinical Cushing's syndrome and adrenocorticotropic hormone-independent bilateral adrenocortical macronodular hyperplasia.
September 1997, Internal medicine (Tokyo, Japan),
S Koizumi, and M Beniko, and A Ikota, and H Mizumoto, and K Matsuya, and A Matsuda, and S Sakuma, and Y Mashio, and H Kunita, and K Okamoto
Adrenocorticotropic hormone-independent bilateral macronodular adrenocortical hyperplasia associated with Cushing's syndrome.
March 1995, Pathology international,
S Koizumi, and M Beniko, and A Ikota, and H Mizumoto, and K Matsuya, and A Matsuda, and S Sakuma, and Y Mashio, and H Kunita, and K Okamoto
Clinical and endocrinological features of adrenocorticotropic hormone- independent bilateral macronodular adrenocortical hyperplasia.
November 2001, The Journal of urology,
S Koizumi, and M Beniko, and A Ikota, and H Mizumoto, and K Matsuya, and A Matsuda, and S Sakuma, and Y Mashio, and H Kunita, and K Okamoto
Non-cushingoid Cushing's syndrome due to adrenocorticotropic hormone-independent bilateral adrenocortical macronodular hyperplasia.
May 1995, Internal medicine (Tokyo, Japan),
S Koizumi, and M Beniko, and A Ikota, and H Mizumoto, and K Matsuya, and A Matsuda, and S Sakuma, and Y Mashio, and H Kunita, and K Okamoto
[ACTH-independent bilateral macronodular adrenocortical hyperplasia (AIMAH): a case report].
April 1999, Hinyokika kiyo. Acta urologica Japonica,
S Koizumi, and M Beniko, and A Ikota, and H Mizumoto, and K Matsuya, and A Matsuda, and S Sakuma, and Y Mashio, and H Kunita, and K Okamoto
[ACTH-independent bilateral adrenocortical macronodular hyperplasia (AIMAH): report of a case].
July 1995, Hinyokika kiyo. Acta urologica Japonica,
S Koizumi, and M Beniko, and A Ikota, and H Mizumoto, and K Matsuya, and A Matsuda, and S Sakuma, and Y Mashio, and H Kunita, and K Okamoto
Adrenocorticotropic hormone independent macronodular adrenal hyperplasia.
July 2011, BMJ case reports,
S Koizumi, and M Beniko, and A Ikota, and H Mizumoto, and K Matsuya, and A Matsuda, and S Sakuma, and Y Mashio, and H Kunita, and K Okamoto
Maffucci Syndrome Associated With Adrenocorticotropic Hormone-Independent Bilateral Macronodular Adrenal Hyperplasia.
January 2017, Journal of the Endocrine Society,
Copied contents to your clipboard!